ID
11719
Description
The purpose of this study is to compare the safety of two different dose regimens of unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction) who have been initially treated with fondaparinux. https://clinicaltrials.gov/ct2/show/NCT00790907
Link
https://clinicaltrials.gov/ct2/show/NCT00790907
Keywords
Versions (1)
- 7/28/15 7/28/15 -
Uploaded on
July 28, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility FUTURA/OASIS 8 Acute Coronary Syndrome NCT00790907
Eligibility Criteria
- StudyEvent: ODM
Description
Exclusion Criteria
Description
Age < 21 years
Data type
boolean
Alias
- UMLS CUI-1
- C0001779
Description
Any contraindication to UFH
Data type
boolean
Alias
- UMLS CUI-1
- C2825026
- UMLS CUI-2
- C0522473
Description
Any contraindication to fondaparinux
Data type
boolean
Alias
- UMLS CUI-1
- C1098510
- UMLS CUI-2
- C0522473
Description
Contraindication for angiography or PCI at baseline
Data type
boolean
Alias
- UMLS CUI-1
- C1532338
- UMLS CUI-2
- C0522473
Description
Contraindication for angiography at baseline
Data type
boolean
Alias
- UMLS CUI-1
- C0085532
- UMLS CUI-2
- C0522473
Description
refractory or recurrent angina associated with dynamic ST-deviation
Data type
boolean
Alias
- UMLS CUI-1
- C0002962
Description
heart failure
Data type
boolean
Alias
- UMLS CUI-1
- C0018801
Description
life-threatening arrhythmias
Data type
boolean
Alias
- UMLS CUI-1
- C0085612
Description
hemodynamic instability
Data type
boolean
Alias
- UMLS CUI-1
- C0948268
Description
Subjects already receiving treatment with enoxaparin for treatment of the qualifying events
Data type
boolean
Alias
- UMLS CUI-1
- C0206460
Description
Subjects already receiving treatment with LMWH for treatment of the qualifying events
Data type
boolean
Alias
- UMLS CUI-1
- C3536766
Description
Subjects already receiving treatment with bivalirudin for treatment of the qualifying events
Data type
boolean
Alias
- UMLS CUI-1
- C0168273
Description
Subjects already receiving treatment with UFH for treatment of the qualifying events
Data type
boolean
Alias
- UMLS CUI-1
- C2825026
Description
Hemorrhagic stroke within the last 12 months.
Data type
boolean
Alias
- UMLS CUI-1
- C0559159
Description
Indication for anti-coagulation other than acute coronary syndrome (ACS) during the index hospitalization.
Data type
boolean
Alias
- UMLS CUI-1
- C0003281
Description
Pregnancy or women of childbearing potential who are not using an effective method of contraception.
Data type
boolean
Alias
- UMLS CUI-1
- C0549206
Description
Co-morbid condition with life expectancy less than 6 months.
Data type
boolean
Alias
- UMLS CUI-1
- C0679247
Description
Currently receiving an experimental pharmacological agent.
Data type
boolean
Alias
- UMLS CUI-1
- C0304229
Description
Revascularization procedure already performed for the qualifying event.
Data type
boolean
Alias
- UMLS CUI-1
- C0027056
Description
Severe renal insufficiency (i.e., estimated creatinine clearance <20 ml/min)
Data type
boolean
Alias
- UMLS CUI-1
- C1533077
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)